Thu 24th Apr 14, 12:52
Despite reporting an decent first-quarter statement, retail-focused property group Hammerson received a ratings downgrade by HSBC on Thursday from 'overweight' to 'neutral' on the back of the stock's recent strong run.
Search news for stories that mention a company:
Show only the stories that interest you with news filter.
Berenberg has reiterated its 'sell' recommendation for pay-TV and broadband group British Sky Broadcasting (BSkyB), saying that the company's upcoming third-quarter statement will probably show signs of market share loss. 31 minutes ago
Leni Gas & Oil (LGO) has decided to not appeal against the verdict in its legal action against fellow AIM explorer Mediterranean Oil & Gas (MOG). 1 hour ago
European stocks moved quickly higher during the morning session after European Central Bank President Mario Draghi sounded a rather dovish note during his speech in the Netherlands. 1 hour ago
Shares in mining minnow Bahamas Petroleum Company (BPC) have leapt on news that a former BP regional chief and a former Bahamas senator have been appointed to the board as the company closes in on farm-out discussions. 1 hour ago
Ahead of Barclays' AGM, this afternoon, analyst Ian Gordon at Investec writes that: "As a generality, we regard the Barclays AGM as a circus which can be safely ignored." However, they quickly add that today's first quarter trading update was more detailed than expected and "appears to be a shade ahead of our expectations." 2 hours ago
FTSE 100 at highest since March 6th; Apple, Facebook surge after the closing bell; AstraZeneca, Anglo American gain after updates. 1 hour ago
Disclaimer: This news feed is provided by Digital Look Ltd. BullBearings Ltd do not necessarily share the views expressed within the stories. The stories are for general information purposes only and not a solicitation or personal reccomendation to deal. BullBearings Ltd accepts no liability or responsibility for any of the content contained in the information provided by Digital Look Ltd.
In this, the first of a series of four articles, I will explain some forex misconceptions are, and outline the feature that is the real “holy grail” of the market. In the following three parts, I will show how a robust trading strategy can be built that will give the new or aspiring trading an edge with an overwhelming probability of profitability over the long run.
In order to begin our journey, it helps to begin with an allegorical story, in order to demonstrate the nature and challenge of the struggle of trading.
Those who have followed me for some years will know I am a fan of seasonality and as I have explained in previous updates, financial markets do not go up or down evenly throughout the year in a nice orderly straight line; that would be far too easy.
If we invested $10,000 in the Dow Jones on 1st November and and then taken our money out on April 30st from 1950 to date we would now have over $950,000. We would have been out of the market May until end of October each year missing a few crashes in the process.
The USD/CHF pair fell during the session on Friday, but did so in a relatively tame manner, leading me to believe there are still opportunities for short-selling.
After all, we have seen for strong selloffs as far as daily candles are concerned, and then have finally see the market settle down for the Friday session.
Cloud computing services provider Nasstar (NASA) has been transformed by its acquisition of rival e-know.net. The integration of the operations is already far advanced and the business should be profitable this year.
e-know.net was established by David Redwood in 2000 and it was much larger than Nasstar, which paid £13m in cash and shares for the company in January and raised £10.5m from a placing at 5p a share.
Shares in Abcam (ABC), the provider of antibodies for the life sciences research and testing sector, have fallen by more than a quarter in recent weeks after a profit warning at the beginning of last month, with some investors clearly now having doubts about the long term future for the company. But new research might indicate things aren't as bad as some doomsayers believe.
Independent antibody search engine CiteAb has released new data today that suggests that this is a temporary dip for Abcam, with a brighter future ahead.